Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
Short descriptor: Inj. byooviz, 0.1 mg
Look up Q5124 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
Q5124 is the HCPCS Level II code for Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Section
- Q: Temporary Codes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2023-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference Q5124 with the canonical source and edition:
Q5124 — Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5124
Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5124